Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Figueroa

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Cancer Cell|August 18, 2012
H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemiaMasahiro Kawahara, Ashley Pandolfi, Boris Bartholdy, et al.
Plos One|March 28, 2008
An integrative genomic and epigenomic approach for the study of transcriptional regulationMaria E Figueroa, Mark Reimers, Reid F Thompson, et al.
Blood|April 12, 2012
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemiaAna Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Erpelinck-Verschueren, et al.
Leukemia|March 30, 2019
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromesAnair Graciela Lema Fernandez, Barbara Crescenzi, Valentina Pierini, et al.
Cancer Cell|September 24, 2013
Epigenetic roles of MLL oncoproteins are dependent on NF-κBHsu-Ping Kuo, Zhong Wang, Dung-Fang Lee, et al.
Clinical Epigenetics|November 18, 2020
5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancersSiyu Liu, Marcell Costa de Medeiros, Evan M Fernandez, et al.
Science Advances|April 11, 2025
Genome-wide methylome modeling via generative AI incorporating long- and short-range interactionsFengyao Yan, Aristeidis G Telonis, Qin Yang, et al.
Blood|August 5, 2009
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylationMaria E Figueroa, Lucy Skrabanek, Yushan Li, et al.
Haematologica|May 4, 2019
Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemiaAllan Beke, Lucie Laplane, Julie Riviere, et al.
Blood|August 3, 2012
CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900Mithat Gönen, Zhuoxin Sun, Maria E Figueroa, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Cancer Cell|August 18, 2012
H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemiaMasahiro Kawahara, Ashley Pandolfi, Boris Bartholdy, et al.
Plos One|March 28, 2008
An integrative genomic and epigenomic approach for the study of transcriptional regulationMaria E Figueroa, Mark Reimers, Reid F Thompson, et al.
Blood|April 12, 2012
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemiaAna Flávia Tibúrcio Ribeiro, Marta Pratcorona, Claudia Erpelinck-Verschueren, et al.
Leukemia|March 30, 2019
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromesAnair Graciela Lema Fernandez, Barbara Crescenzi, Valentina Pierini, et al.
Cancer Cell|September 24, 2013
Epigenetic roles of MLL oncoproteins are dependent on NF-κBHsu-Ping Kuo, Zhong Wang, Dung-Fang Lee, et al.
Clinical Epigenetics|November 18, 2020
5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancersSiyu Liu, Marcell Costa de Medeiros, Evan M Fernandez, et al.
Science Advances|April 11, 2025
Genome-wide methylome modeling via generative AI incorporating long- and short-range interactionsFengyao Yan, Aristeidis G Telonis, Qin Yang, et al.
Blood|August 5, 2009
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylationMaria E Figueroa, Lucy Skrabanek, Yushan Li, et al.
Haematologica|May 4, 2019
Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemiaAllan Beke, Lucie Laplane, Julie Riviere, et al.
Blood|August 3, 2012
CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900Mithat Gönen, Zhuoxin Sun, Maria E Figueroa, et al.
Pageof 9